Enzo Biochem, Inc.
SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS INFECTION

Last updated:

Abstract:

The invention provides methods and compositions for treating a coronavirus infection using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.

Status:
Application
Type:

Utility

Filling date:

10 Mar 2021

Issue date:

23 Sep 2021